AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated March 11, 2024, titled "Intimation about Distribution and Promotion Agreement between AstraZeneca Pharma India Limited ("Company") and Mankind Pharma Limited for innovative budesonide and formoterol fumarate dihydrate (Symbicort)".